Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 29.55
+0.25 (0.85%)
Sep 30, 2026, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 15.85 billion as of September 29, 2026. Its market cap has decreased by -7.28% in one year.
Market Cap
15.85B
Enterprise Value
17.62B
Revenue
6.68B
Ranking
n/a
PE Ratio
19.18
Stock Price
29.55
ChartMarket Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.85B, an increase of 2,617.32%. That is a compound annual growth rate of 17.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 15.85B | -2.42% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 24.48B |
| Handa Pharmaceuticals | 20.15B |
| TTY Biopharm Company | 19.47B |
| YungShin Global Holding | 14.92B |
| ScinoPharm Taiwan | 14.71B |
| Grape King Bio | 12.89B |
| Foresee Pharmaceuticals | 12.63B |
| Standard Chemical & Pharmaceutical | 10.04B |